Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes

BMC Medicine

CW le Roux²  T Olbers²  KJ Neff¹ 

[1] Experimental Pathology, UCD Conway Institute, School of Medicine and Medical Sciences, University College Dublin, Belfield, Dublin 4, Dublin, Ireland;Department of Gastrosurgical Research and Education, University of Gothenburg, 5-413 45 Gothenburg, Sweden

关键词: postoperative outcomes.;    pre-operative assessment;    obesity;    Bariatric surgery;   

Others  :  857232
DOI  :  10.1186/1741-7015-11-8

 received in 2012-04-13, accepted in 2013-01-10,  发布年份 2013

【 摘 要 】

Obesity is recognized as a global health crisis. Bariatric surgery offers a treatment that can reduce weight, induce remission of obesity-related diseases, and improve the quality of life. In this article, we outline the different options in bariatric surgery and summarize the recommendations for selecting and assessing potential candidates before proceeding to surgery. We present current data on post-surgical outcomes and evaluate the psychosocial and economic effects of bariatric surgery. Finally, we evaluate the complication rates and present recommendations for post-operative care.

【 授权许可】

   
2013 Neff et al; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]World Health Organization: Global Strategy on Diet, Physical Activity and Health. Geneva, Switzerland; 2011. [updated June 2012]; Available from: [http://www.who.int/dietphysicalactivity/publications/obesity/en/index.html webcite]
• [2]Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A, Garside DB, Dyer AR, Van Horn L, Liao Y, Fries JF, Greenland P: Midlife body mass index and hospitalization and mortality in older age. JAMA 2006, 295:190-198.
• [3]Vlad I: Obesity costs UK economy 2bn pounds sterling a year. BMJ 2003, 327:1308.
• [4]Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H, Swedish Obese Study Scientific Group: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
• [5]O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Chapman L, Anderson M: Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006, 144:625-633.
• [6]Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC: Long-term mortality after gastric bypass surgery. N Engl J Med 2007, 357:753-761.
• [7]Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM, Swedish Obese Subjects Study: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752.
• [8]Buchwald H, Oien DM: Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009, 19:1605-1611.
• [9]Smith BR, Schauer P, Nguyen NT: Surgical approaches to the treatment of obesity: bariatric surgery. Med Clin North Am 2011, 95:1009-1030.
• [10]Reoch J, Mottillo S, Shimony A, Filion KB, Christou NV, Joseph L, Poirier P, Eisenberg MJ: Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg 2011, 146:1314-1322.
• [11]O'Brien PE, Dixon JB, Laurie C, Anderson M: A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg 2005, 15:820-826.
• [12]Scott WR, Batterham RL: Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 2011, 301:R15-27.
• [13]Scopinaro N, Gianetta E, Pandolfo N, Anfossi A, Berretti B, Bachi V: [Bilio- pancreatic bypass. Proposal and preliminary experimental study of a new type of operation for the functional surgical treatment of obesity]. Minerva Chir 1976, 31:560-566.
• [14]Hess DS, Hess DW: Biliopancreatic diversion with a duodenal switch. Obes Surg 1998, 8:267-282.
• [15]Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, Laycock W, Adrales G, Vassiliou M, Szomstein S, Heller S, Joyce AM, Heiss F, Nepomnayshy D: Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010, 71:976-982.
• [16]Espinet-Coll E, Nebreda-Duran J, Gomez-Valero JA, Munoz-Navas M, Pujol-Gebelli J, Vila-Lolo C, Martinez-Gomez A, Juan-Creix-Comamaia A: Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig 2012, 104:72-87.
• [17]Tarnoff M, Rodriguez L, Escalona A, Ramos A, Neto M, Alamo M, Reyes E, Pimentel F, Ibanez L: Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009, 23:650-656.
• [18]Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, Greve JW: A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010, 251:236-243.
• [19]Centre for Public Health Excellence at NICE (UK), National Collaborating Centre for Primary Care (UK): Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London. 2006.
• [20]NIH Consensus Development Conference Panel: Gastrointestinal surgery for severe obesity. Ann Intern Med 1991, 115:956-961.
• [21]Serrot FJ, Dorman RB, Miller CJ, Slusarek B, Sampson B, Sick BT, Leslie DB, Buchwald H, Ikramuddin S: Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index < 35 kg/m2. Surgery 2011, 150:684-691.
• [22]Ogden J, Avenell S, Ellis G: Negotiating control: patients' experiences of unsuccessful weight-loss surgery. Psychol Health 2011, 26:949-964.
• [23]Saltzman E, Anderson W, Apovian CM, Boulton H, Chamberlain A, Cullum-Dugan D, Cummings S, Hatchigian E, Hodges B, Keroack CR, Pettus M, Thomason P, Veglia L, Young LS: Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005, 13:234-243.
• [24]Catheline JM, Bihan H, Le Quang T, Sadoun D, Charniot JC, Onnen I, Fournier JL, Bénichou J, Cohen R: Preoperative cardiac and pulmonary assessment in bariatric surgery. Obes Surg 2008, 18:271-277.
• [25]Association of Anaesthetists of Great Britain and Ireland: Peri-operative Management of the Morbidly Obese Patient. London 2007. [cited 12 June 2012]; [http://www.aagbi.org/publications/guidelines/docs/Obesity07.pdf webcite]
• [26]Ravesloot MJ, van Maanen JP, Hilgevoord AA, van Wagensveld BA, de Vrie N: Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012, 269:1865-1871.
• [27]Carneiro G, Florio RT, Zanella MT, Pradella-Hallinan M, Ribeiro-Filho FF, Tufik S, Togeiro SM: Is mandatory screening for obstructive sleep apnea with polysomnography in all severely obese patients indicated? Sleep Breath 2012, 16:163-168.
• [28]Weingarten TN, Flores AS, McKenzie JA, Nguyen LT, Robinson WB, Kinney TM, Siems BT, Wenzel PJ, Sarr MG, Marienau MS, Schroeder DR, Olson EJ, Morgenthaler TI, Warner DO, Sprung J: Obstructive sleep apnoea and perioperative complications in bariatric patients. Br J Anaesth 2011, 106:131-139.
• [29]Nguyen NT, Masoomi H, Laugenour K, Sanaiha Y, Reavis KM, Mills SD, Stamos MJ: Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample. Surgery 2011, 150:347-351.
• [30]Alvarado R, Alami RS, Hsu G, Safadi BY, Sanchez BR, Morton JM, Curet MJ: The impact of preoperative weight loss in patients undergoing laparoscopic Roux- en-Y gastric bypass. Obes Surg 2005, 15:1282-1286.
• [31]Alami RS, Morton JM, Schuster R, Lie J, Sanchez BR, Peters A, Curet MJ: Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis 2007, 3:141-145. discussion 5-6
• [32]Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, Ko CY, Meehan MM: Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg 2012, 22:70-89.
• [33]Mul JD, Begg DP, Alsters SI, van Haaften G, Duran KJ, D'Alessio DA, le Roux CW, Woods SC, Sandoval DA, Blakemore AI, Cuppen E, van Haelst MM, Seeley RJ: Effect of vertical sleeve gastrectomy in melanocortin receptor 4-deficient rats. Am J Physiol Endocrinol Metab 2012, 303:E103-110.
• [34]Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR, Bromberg Y, Pennacchio LA, Dent R, McPherson R, Ahituv N, Vaisse C: Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case- control study. Hum Mol Genet 2009, 18:1140-1147.
• [35]Ranadive SA, Vaisse C: Lessons from extreme human obesity: monogenic disorders. Endocrinol Metab Clin North Am 2008, 37:733-751.
• [36]Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjostrom L, Bouchard C, Carlsson LM: Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) 2011, 35:676-683.
• [37]Liou TH, Chen HH, Wang W, Wu SF, Lee YC, Yang WS, Lee WJ: ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients. Obes Surg 2011, 21:1758-1765.
• [38]Harvey SB, Zhang Y, Wilson-Grady J, Monkkonen T, Nelsestuen GL, Kasthuri RS, Verneris MR, Lund TC, Ely EW, Bernard GR, Zeisler H, Homoncik M, Jilma B, Swan T, Kellogg TA: O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res 2009, 8:603-612.
• [39]Kim K, Perroud B, Espinal G, Kachinskas D, Austrheim-Smith I, Wolfe BM, Warden CH: Genes and networks expressed in perioperative omental adipose tissue are correlated with weight loss from Roux-en-Y gastric bypass. Int J Obes (Lond) 2008, 32:1395-1406.
• [40]Kim K, Zakharkin SO, Allison DB: Expectations, validity, and reality in gene expression profiling. J Clin Epidemiol 2010, 63:950-959.
• [41]Piaggi P, Lippi C, Fierabracci P, Maffei M, Calderone A, Mauri M, Anselmino M, Cassano GB, Vitti P, Pinchera A, Landi A, Santini F: Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. PloS One 2010, 5:e13624.
• [42]Lee WJ, Chong K, Ser KH, Chen JC, Lee YC, Chen SC, Su YH, Tsai MH: C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg 2012, 22:293-298.
• [43]Dixon JB, Chuang LM, Chong K, Chen SC, Lambert GW, Straznicky NE, Lambert EA, Lee WJ: Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care, in press.
• [44]Hayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS: A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 2011, 21:910-916.
• [45]Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC, Lee YC, Ser KH: Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis, in press.
• [46]le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T: Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007, 246:780-785.
• [47]Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, Bekker JH, Ghatei MA, Bloom SR, Walters JR, Welbourn R, le Roux CW: The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012, 153:3613-3619.
• [48]le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR: Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006, 243:108-114.
• [49]Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ: Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006, 93:210-215.
• [50]Angrisani L, Lorenzo M, Borrelli V: Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 2007, 3:127-132. discussion 32-3
• [51]Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD: Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008, 121:885-893.
• [52]O'Brien PE, McPhail T, Chaston TB, Dixon JB: Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006, 16:1032-1040.
• [53]Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F: Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg 2011, 21:1650-1656.
• [54]Clinical Issues Committee of American Society for Metabolic and Bariatric Surgery: Sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 2007, 3:573-576.
• [55]Himpens J, Dobbeleir J, Peeters G: Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Sur 2010, 252:319-324.
• [56]Laurenius A, Taha O, Maleckas A, Lonroth H, Olbers T: Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects. Surg Obes Relat Dis 2010, 6:408-414.
• [57]Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
• [58]Sovik TT, Aasheim ET, Taha O, Engstrom M, Fagerland MW, Bjorkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T: Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med 2011, 155:281-291.
• [59]Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK: Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008, 247:401-407.
• [60]Prachand VN, Ward M, Alverdy JC: Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass. J Gastrointest Surg 2010, 14:211-220.
• [61]Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I: Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009, 122:248-256. e5
• [62]Hedberg J, Sundbom M: Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial. Surg Obes Relat Dis 2012, 8:338-343.
• [63]Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL: Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012, 366:1567-1576.
• [64]Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F: Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012, 366:1577-1585.
• [65]Wei YF, Tseng WK, Huang CK, Tai CM, Hsuan CF, Wu HD: Surgically induced weight loss, including reduction in waist circumference, is associated with improved pulmonary function in obese patients. Surg Obes Relat Dis 2011, 7:599-604.
• [66]Gutschow CA, Collet P, Prenzel K, Holscher AH, Schneider PM: Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. J Gastrointest Surg 2005, 9:941-948.
• [67]Prachand VN, Alverdy JC: Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery? World J Gastroenterol 2010, 16:3757-3761.
• [68]Greenburg DL, Lettieri CJ, Eliasson AH: Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009, 122:535-542.
• [69]Boulet LP, Turcotte H, Martin J, Poirier P: Effect of bariatric surgery on airway response and lung function in obese subjects with asthma. Resp Med 2012, 106:651-660.
• [70]Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB: Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
• [71]Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lönroth H, Narbro K, Näslund I, Olbers T, Svensson PA, Carlsson LM: Bariatric surgery and long-term cardiovascular events. JAMA 2012, 307:56-65.
• [72]Hofso D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J, Hjelmesaeth J: Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010, 163:735-745.
• [73]Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, Hashimi MW, Mukerji V: Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 1995, 76:1194-1197.
• [74]Lakhani M, Fein S: Effects of obesity and subsequent weight reduction on left ventricular function. Cardiol Rev 2011, 19:1-4.
• [75]Ashrafian H, le Roux CW, Darzi A, Athanasiou T: Effects of bariatric surgery on cardiovascular function. Circulation 2008, 118:2091-2102.
• [76]Leibson CL, Williamson DF, Melton LJ, Palumbo PJ, Smith SA, Ransom JE, Schilling PL, Narayan KM: Temporal trends in BMI among adults with diabetes. Diabetes Care 2001, 24:1584-1589.
• [77]Benaiges D, Goday A, Ramon JM, Hernandez E, Pera M, Cano JF: Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis 2011, 7:575-580.
• [78]MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ: The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997, 1:213-220. discussion 20
• [79]Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L, Gniuli D, Nanni G, Castagneto M, Ghirlanda G, Mingrone G: Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 2011, 34:561-567.
• [80]Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M: Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002, 162:2061-2069.
• [81]Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M: Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378:815-825.
• [82]Herpertz S, Kielmann R, Wolf AM, Langkafel M, Senf W, Hebebrand J: Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord 2003, 27:1300-1314.
• [83]Narbro K, Agren G, Jonsson E, Larsson B, Naslund I, Wedel H, Sjostrom L: Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 1999, 23:619-624.
• [84]Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M: A study on the economic impact of bariatric surgery. Am J Manag Care 2008, 14:589-596.
• [85]Neovius M, Narbro K, Keating C, Peltonen M, Sjoholm K, Agren G, Sjostrom L, Carlsson L: Healthcare use during 20 years following bariatric surgery. JAMA 2012, 308:1132-1141.
• [86]Wadden TA, Sarwer DB, Fabricatore AN, Jones L, Stack R, Williams NS: Psychosocial and behavioral status of patients undergoing bariatric surgery: what to expect before and after surgery. Med Clin North Am 2007, 91:451-469. xi-xii
• [87]Peltonen M, Lindroos AK, Torgerson JS: Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain 2003, 104:549-557.
• [88]Traish AM, Feeley RJ, Guay A: Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS J 2009, 276:5755-5767.
• [89]Kort HI, Massey JB, Elsner CW, Mitchell-Leef D, Shapiro DB, Witt MA, Roudebush WE: Impact of body mass index values on sperm quantity and quality. J Androl 2006, 27:450-452.
• [90]Bastounis EA, Karayiannakis AJ, Syrigos K, Zbar A, Makri GG, Alexiou D: Sex hormone changes in morbidly obese patients after vertical banded gastroplasty. Eur Surg Res 1998, 30:43-47.
• [91]Sermondade N, Massin N, Boitrelle F, Pfeffer J, Eustache F, Sifer C, Czemichow S, Levy R: Sperm parameters and male fertility after bariatric surgery: three case series. Reprod Biomed Online 2012, 24:206-210.
• [92]Boots C, Stephenson MD: Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Sem Reprod Med 2011, 29:507-513.
• [93]Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millan JL: The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005, 90:6364-6369.
• [94]Maggard MA, Yermilov I, Li Z, Maglione M, Newberry S, Suttorp M, Hilton L, Santry HP, Morton JM, Livingston EH, Shekelle PG: Pregnancy and fertility following bariatric surgery: a systematic review. JAMA 2008, 300:2286-2296.
• [95]Dalfra MG, Busetto L, Chilelli NC, Lapolla A: Pregnancy and foetal outcome after bariatric surgery: a review of recent studies. J Matern-fetal Neonatal Med 2012, 25:1537-1543.
• [96]Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M: Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond) 2007, 31:1248-1261.
• [97]de Zwaan M, Enderle J, Wagner S, Muhlhans B, Ditzen B, Gefeller O, Mitchell JE, Muller A: Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. J Affect Disord 2011, 133:61-68.
• [98]Hell E, Miller KA, Moorehead MK, Norman S: Evaluation of health status and quality of life after bariatric surgery: comparison of standard Roux-en-Y gastric bypass, vertical banded gastroplasty and laparoscopic adjustable silicone gastric banding. Obes Surg 2000, 10:214-219.
• [99]Hrabosky JI, Masheb RM, White MA, Rothschild BS, Burke-Martindale CH, Grilo CM: A prospective study of body dissatisfaction and concerns in extremely obese gastric bypass patients: 6- and 12-month postoperative outcomes. Obes Surg 2006, 16:1615-1621.
• [100]Ratcliff MB, Eshleman KE, Reiter-Purtill J, Zeller MH: Prospective changes in body image dissatisfaction among adolescent bariatric patients: the importance of body size estimation. Surg Obes Relat Dis 2012, 8:470-475.
• [101]Sarwer DB, Wadden TA, Moore RH, Eisenberg MH, Raper SE, Williams NN: Changes in quality of life and body image after gastric bypass surgery. Surg Obes Relat Dis 2010, 6:608-614.
• [102]Zeller MH, Reiter-Purtill J, Ratcliff MB, Inge TH, Noll JG: Two-year trends in psychosocial functioning after adolescent Roux-en-Y gastric bypass. Surg Obes Relat Dis 2011, 7:727-732.
• [103]Colles SL, Dixon JB, O'Brien PE: Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity (Silver Spring) 2008, 16:615-622.
• [104]Wong A, Fitzgerald RC: Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005, 3:1-10.
• [105]Csendes A, Burgos AM, Smok G, Burdiles P, Henriquez A: Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg 2006, 10:259-264.
• [106]Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A: Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005, 46:233-241.
• [107]Turgeon NA, Perez S, Mondestin M, Davis SS, Lin E, Tata S, Kirk AD, Larsen CP, Pearson TC, Sweeney JF: The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol 2012, 23:885-894.
• [108]Navarro-Diaz M, Serra A, Romero R, Bonet J, Bayes B, Homs M, Perez N, Bonal J: Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006, 17:S213-217.
• [109]Afshinnia F, Wilt TJ, Duval S, Esmaeili A, Ibrahim HN: Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010, 25:1173-1183.
• [110]Li Z, Clark J, Diehl AM: The liver in obesity and type 2 diabetes mellitus. Clin Liver Dis 2002, 6:867-877.
• [111]Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M: Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 2010, (1):CD007340.
• [112]Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, Jacobson P, Karason K, Karlsson J, Larsson B, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Carlsson LM, Swedish Obese Subjects Study: Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009, 10:653-662.
• [113]Ashrafian H, Ahmed K, Rowland SP, Patel VM, Gooderham NJ, Holmes E, Darzi A, Athanasiou T: Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer 2011, 117:1788-1799.
• [114]Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E, Pomp A, Staten MA, Yanovski SZ, Thirlby R, Wolfe B: Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009, 361:445-454.
• [115]Nguyen NT, Rivers R, Wolfe BM: Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg 2003, 197:548-555. discussion 55-57
• [116]Smith MD, Patterson E, Wahed AS, Belle SH, Berk PD, Courcoulas AP, Dakin GF, Flum DR, Machado L, Mitchell JE, Pender J, Pomp A, Pories W, Ramanathan R, Schrope B, Staten M, Ude A, Wolfe BM: Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg 2011, 21:1687-1692.
• [117]Carucci LR, Turner MA, Conklin RC, DeMaria EJ, Kellum JM, Sugerman HJ: Roux-en-Y gastric bypass surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series. Radiology 2006, 238:119-127.
• [118]Simon TE, Scott JA, Brockmeyer JR, Rice RC, Frizzi JD, Husain FA, Choi YU: Comparison of staple-line leakage and hemorrhage in patients undergoing laparoscopic sleeve gastrectomy with or without Seamguard. Am Surg 2011, 77:1665-1668.
• [119]Mitchell MT, Carabetta JM, Shah RN, O'Riordan MA, Gasparaitis AE, Alverdy JC: Duodenal switch gastric bypass surgery for morbid obesity: imaging of postsurgical anatomy and postoperative gastrointestinal complications. AJR Am J Roentgenol 2009, 193:1576-1580.
• [120]Cunneen SA: Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2008, 4:S47-55.
• [121]Mehran A, Szomstein S, Zundel N, Rosenthal R: Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2003, 13:842-847.
• [122]Sakran N, Assalia A, Sternberg A, Kluger Y, Troitsa A, Brauner E, Van Cauwenberge S, De Visschere M, Dillemans B: Smaller staple height for circular stapled gastrojejunostomy in laparoscopic gastric bypass: early results in 1,074 morbidly obese patients. Obes Surg 2011, 21:238-243.
• [123]Rabl C, Peeva S, Prado K, James AW, Rogers SJ, Posselt A, Campos GM: Early and late abdominal bleeding after Roux-en-Y gastric bypass: sources and tailored therapeutic strategies. Obes Surg 2011, 21:413-420.
• [124]Frezza EE, Reddy S, Gee LL, Wachtel MS: Complications after sleeve gastrectomy for morbid obesity. Obes Surg 2009, 19:684-687.
• [125]Daskalakis M, Berdan Y, Theodoridou S, Weigand G, Weiner RA: Impact of surgeon experience and buttress material on postoperative complications after laparoscopic sleeve gastrectomy. Surg Endosc 2011, 25:88-97.
• [126]Dillemans B, Sakran N, Van Cauwenberge S, Sablon T, Defoort B, Van Dessel E, Akin F, Moreels N, Lambert S, Mulier J, Date R, Vandelanotte M, Feryn T, Proot L: Standardization of the fully stapled laparoscopic Roux-en-Y gastric bypass for obesity reduces early immediate postoperative morbidity and mortality: a single center study on 2606 patients. Obes Surg 2009, 19:1355-1364.
• [127]Nguyen NT, Wilson SE: Complications of antiobesity surgery. Nat Clin Pract Gastroenterol Hepatol 2007, 4:138-147.
• [128]Crea N, Pata G, Di Betta E, Greco F, Casella C, Vilardi A, Mittempegher F: Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity. Obes Surg 2011, 21:139-145.
• [129]Rodriguez A, Mosti M, Sierra M, Perez-Johnson R, Flores S, Dominguez G, Sánchez H, Zarco A, Romay K, Herrera MF: Small bowel obstruction after antecolic and antegastric laparoscopic Roux-en-Y gastric bypass: could the incidence be reduced? Obes Surg 2010, 20:1380-1384.
• [130]Nguyen NT, Stevens CM, Wolfe BM: Incidence and outcome of anastomotic stricture after laparoscopic gastric bypass. J Gastrointest Surg 2003, 7:997-1003.
• [131]Mathew A, Veliuona MA, DePalma FJ, Cooney RN: Gastrojejunal stricture after gastric bypass and efficacy of endoscopic intervention. Dig Dis Sci 2009, 54:1971-1978.
• [132]Bolen SD, Chang HY, Weiner JP, Richards TM, Shore AD, Goodwin SM, Johns RA, Magnuson TH, Clark JM: Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states. Obes Surg 2012, 22:749-763.
• [133]Csendes A, Torres J, Burgos AM: Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes Surg 2011, 21:1319-1322.
• [134]Thornton CM, Rozen WM, So D, Kaplan ED, Wilkinson S: Reducing band slippage in laparoscopic adjustable gastric banding: the mesh plication pars flaccida technique. Obes Surg 2009, 19:1702-1706.
• [135]Bernante P, Francini Pesenti F, Toniato A, Zangrandi F, Pomerri F, Pelizzo MR: Obstructive symptoms associated with the 9.75-cm Lap-Band in the first 24 hours using the pars flaccida approach. Obes Surg 2005, 15:357-360.
• [136]Allen JW: Laparoscopic gastric band complications. Med Clin North Am 2007, 91:485-497. xii
• [137]O'Brien PE, Dixon JB: Weight loss and early and late complications--the international experience. Am J Surg 2002, 184:42S-45S.
• [138]Favretti F, Segato G, Ashton D, Busetto L, De Luca M, Mazza M, Ceoloni A, Banzato O, Calo E, Enzi G: Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg 2007, 17:168-175.
• [139]Chakravarty PD, McLaughlin E, Whittaker D, Byrne E, Cowan E, Xu K, Bruce DM, Ford JA: Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 2012, 10:172-182.
• [140]Ziegler O, Sirveaux MA, Brunaud L, Reibel N, Quilliot D: Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabet Metab 2009, 35:544-557.
• [141]Fujioka K: Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care 2005, 28:481-484.
• [142]Roberson EN, Gould JC, Wald A: Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci 2010, 55:2606-2613.
• [143]Poylin V, Serrot FJ, Madoff RD, Ikramuddin S, Mellgren A, Lowry AC, Melton GB: Obesity and bariatric surgery: a systematic review of associations with defecatory dysfunction. Colorectal Dis 2011, 13:e92-103.
• [144]Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R: Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009, 6:583-590.
• [145]Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ, Patti ME: Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007, 92:4678-4685.
• [146]Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK: Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 2011, 167:199-205.
• [147]Spanakis E, Gragnoli C: Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 2009, 19:1333-1334.
• [148]Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB: Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005, 48:2236-2240.
• [149]Boza C, Gamboa C, Perez G, Crovari F, Escalona A, Pimentel F, Raddatz A, Guzman S, Ibáñez L: Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up. Surg Endosc 2011, 25:292-297.
• [150]Hamdan K, Somers S, Chand M: Management of late postoperative complications of bariatric surgery. Br J Surg 2011, 98:1345-1355.
• [151]Shimizu H, Timratana P, Schauer PR, Rogula T: Review of metabolic surgery for type 2 diabetes in patients with a BMI < 35 kg/m(2). J Obes 2012, 2012:147256.
• [152]Mirshahi UL, Still CD, Masker KK, Gerhard GS, Carey DJ, Mirshahi T: The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2011, 96:E2088-2096.
• [153]Potoczna N, Branson R, Kral JG, Piec G, Steffen R, Ricklin T, Hoehe MR, Lentes KU, Horber FF: Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 2004, 8:971-981. discussion 81-2